A review now published in the Journal of Experimental & Clinical Cancer Research offers a sweeping and authoritative ...

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

Natera, Inc. , a global leader in cell-free DNA and precision medicine, will present multiple datasets in breast cancer together with its collaborators at the 2025 ESMO Breast Cancer Annual Congress ...

At the intersection of radiation and precision, Novartis, Bayer, AstraZeneca and more hope to cash in on a ...

A study conducted by researchers from the Agency for Science, Technology and Research (A*STAR), National Cancer Centre Singapore (NCCS) and National University of Singapore (NUS), in collaboration ...

Feb. 7, 2025 — Pancreatic cancer patients may benefit from future precision treatments as ... have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer ...

Belgium’s breast cancer patients are often left without reimbursed treatments, exposing a growing gap between precision ...

In this interview, industry expert Dr. Lohit Khera discusses the evolving role of microRNA in research, diagnostics, and ...

Women diagnosed with DCIS face a threefold higher risk of breast cancer mortality. Learn the warning signs, treatment options ...

Apr. 11, 2025 — Researchers have found that tapping into the body's own immune system and activating a type of immune cell known as ... a test to detect circulating tumor DNA can predict lung ...